Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancerW Jonat, M Kaufmann, R W Blamey, et al.
Lancet (London, England)|January 11, 2005
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerA Howell, J Cuzick, M Baum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
The sequential use of endocrine treatment for advanced breast cancer: where are we?C Barrios, J F Forbes, W Jonat, et al.
Lancet (London, England)|December 6, 2005
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trialD J Adam, J D Beard, T Cleveland, et al.
Breast Cancer Research and Treatment|April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Lancet (London, England)|May 11, 1996
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study GroupC Hürny, J Bernhard, A S Coates, et al.
British Journal of Cancer|September 23, 1998
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)J Bernhard, C Hürny, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VIIA Wallgren, M Bonetti, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group reportP Karlsson, B F Cole, B H Chua, et al.
British Journal of Cancer|November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancerJ Bernhard, D Zahrieh, J J Zhang, et al.
Pageof 7